Abdul Shlebak

655 total citations
17 papers, 487 citations indexed

About

Abdul Shlebak is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Abdul Shlebak has authored 17 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 5 papers in Hematology. Recurrent topics in Abdul Shlebak's work include Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Platelet Disorders and Treatments (2 papers). Abdul Shlebak is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Platelet Disorders and Treatments (2 papers). Abdul Shlebak collaborates with scholars based in United Kingdom, South Africa and Iceland. Abdul Shlebak's co-authors include Z. Holmes, L. Regan, M. Backos, Raj Rai, Hannah Cohen, Kevin Marriott, Peter Clark, David B. Smith, Jeremy Chataway and Myrtle Y. Gordon and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and Human Reproduction.

In The Last Decade

Abdul Shlebak

17 papers receiving 475 citations

Peers

Abdul Shlebak

HEMAT

CCM

GENET

Brahim Nsiri Tunisia

Cristina Falcó Spain

Yonca Eğin Türkiye

Tamara Brunelli Italy

Hui‐Yu Huang Taiwan

Irene Resch Austria

J. Topping United Kingdom

Alev Akyol Erikçi Türkiye

Jane M. Benson United States

E Lavenne-Pardonge Belgium

Brahim Nsiri Tunisia

Abdul Shlebak

234 ×1.3

HEMAT

77 ×0.6

80 ×0.8

CCM

96 ×0.9

GENET

51 ×0.7

Citations per year, relative to Abdul Shlebak Abdul Shlebak (= 1×) peers Brahim Nsiri

Countries citing papers authored by Abdul Shlebak

Since Specialization

Citations

This map shows the geographic impact of Abdul Shlebak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Shlebak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Shlebak more than expected).

Fields of papers citing papers by Abdul Shlebak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul Shlebak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Shlebak. The network helps show where Abdul Shlebak may publish in the future.

Co-authorship network of co-authors of Abdul Shlebak

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul Shlebak. A scholar is included among the top collaborators of Abdul Shlebak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul Shlebak. Abdul Shlebak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shlebak, Abdul, Michael Laffan, Deepa J. Arachchillage, et al.. (2021). Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19). Seminars in Thrombosis and Hemostasis. 47(4). 436–441. 5 indexed citations

Beshyah, Salem, et al.. (2018). The year in ramadan fasting research (2017): A narrative review. Ibnosina Journal of Medicine and Biomedical Sciences. 10(2). 39–53. 21 indexed citations

Shlebak, Abdul & Barbara J. Bain. (2017). Training future haematologists, a privilege or a burden? “A trainer's view”. British Journal of Haematology. 178(4). 501–507. 4 indexed citations

Shlebak, Abdul, et al.. (2016). A novel mutation in exon 2 of FGB caused by c.221G>T † substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu † ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and arterial thrombosis. Journal of Thrombosis and Thrombolysis. 43(2). 263–270. 5 indexed citations

Shlebak, Abdul, et al.. (2016). The impact of the DoH Commissioning for Quality and Innovation incentive on the success of venous thromboembolism risk assessment in hospitalised patients. A single institution experience in a quality outcome improvement over a 4-year cycle. JRSM Open. 7(6). 443857790–443857790. 3 indexed citations

Shlebak, Abdul, et al.. (2015). A Novel Homozygous c.800C>G Substitution in <b><i>GP1BA</i></b> Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome. Acta Haematologica. 134(3). 193–198. 2 indexed citations

Shlebak, Abdul. (2015). Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review. Journal of Clinical Pathology. 69(4). 337–343. 12 indexed citations

Campbell, Victoria, Kevin Marriott, Rex Stanbridge, & Abdul Shlebak. (2015). Successful Aortic Aneurysm Repair in a Woman with Severe von Willebrand (Type 3) Disease. SHILAP Revista de lepidopterología. 2015. 1–8. 1 indexed citations

Banerjee, Soma, Paul Bentley, Mohammad Hamady, et al.. (2014). Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke. Stem Cells Translational Medicine. 3(11). 1322–1330. 120 indexed citations

10.

Shlebak, Abdul. (2013). Novel oral anticoagulants: A new era in anti-thrombotic therapy. Ibnosina Journal of Medicine and Biomedical Sciences. 5(5). 247–253. 1 indexed citations

11.

Coulson, Samantha, et al.. (2012). An unusual cause of bleeding in an elderly patient. Clinical Medicine. 12(2). 150–152. 1 indexed citations

12.

Thursz, Mark, et al.. (2005). Venous Thromboprophylaxis in Uk Medical Inpatients. Journal of the Royal Society of Medicine. 98(11). 507–512. 31 indexed citations

13.

Bose, Patrick, Simon Black, Mamed Kadyrov, et al.. (2004). Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. American Journal of Obstetrics and Gynecology. 191(6). 2125–2131. 63 indexed citations

14.

Rai, Raj, Abdul Shlebak, Hannah Cohen, et al.. (2001). Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction. 16(5). 961–965. 140 indexed citations

15.

Shlebak, Abdul & David B. Smith. (1997). Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and / or hormonal therapy. Cancer Chemotherapy and Pharmacology. 39(5). 462–466. 22 indexed citations

16.

Shlebak, Abdul, et al.. (1995). Hypersensitivity and cross-reactivity to cisplatin and analogues. Cancer Chemotherapy and Pharmacology. 35(4). 349–351. 47 indexed citations

17.

Clark, Richard E., Abdul Shlebak, & Michael Desmond Creagh. (1994). Delayed Commencement of Granulocyte Colony-Stimulating Factor Following Autologous Bone Marrow Transplantation Accelerates Neutrophil Recovery and Is Cost-Effective. Leukemia & lymphoma. 16(1-2). 141–146. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact